<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ncp.sagepub.com">
<title>Nutrition in Clinical Practice recent issues</title>
<link>http://ncp.sagepub.com</link>
<description>Nutrition in Clinical Practice RSS feed -- recent issues</description>
<prism:publicationName>Nutrition in Clinical Practice</prism:publicationName>
<prism:issn>0884-5336</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/540?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/541?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/543?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/5/549?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/5/560?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/5/578?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/5/589?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/5/609?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/5/616?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/5/626?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/5/635?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/642?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/645?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/647?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/649?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/650?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/651?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/654?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/5/655?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/4/430?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/4/433?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/4/436?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/441?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/447?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/459?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/470?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/481?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/487?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/500?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/508?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/513?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/4/520?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/3/297?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/305?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/316?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/325?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/335?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/344?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/356?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/363?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/377?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/388?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/395?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/414?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/3/419?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/2/175?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/2/176?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/179?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/196?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/206?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/214?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/217?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/227?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/242?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/250?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/261?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/274?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/content/abstract/24/2/281?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/2/284?rss=1" />
  <rdf:li rdf:resource="http://ncp.sagepub.com/cgi/reprint/24/2/285?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://ncp.sagepub.com:80/icons/banner/title.gif" />
</channel>

<image rdf:about="http://ncp.sagepub.com:80/icons/banner/title.gif">
<title>Nutrition in Clinical Practice</title>
<url>http://ncp.sagepub.com:80/icons/banner/title.gif</url>
<link>http://ncp.sagepub.com</link>
</image>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/540?rss=1">
<title><![CDATA[Editor's Note]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/540?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:04 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609348210</dc:identifier>
<dc:title><![CDATA[Editor's Note]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>540</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>540</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/541?rss=1">
<title><![CDATA[Evidence-Based Nutrition Support: Is a Recession a Good Thing?]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/541?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Seres, D. S.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:04 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609343936</dc:identifier>
<dc:title><![CDATA[Evidence-Based Nutrition Support: Is a Recession a Good Thing?]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>542</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>541</prism:startingPage>
<prism:section>Invited Commentary</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/543?rss=1">
<title><![CDATA[Issues in Complementary and Alternative Nutrition Treatments]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/543?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mullin, G. E.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:04 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609343937</dc:identifier>
<dc:title><![CDATA[Issues in Complementary and Alternative Nutrition Treatments]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>548</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>543</prism:startingPage>
<prism:section>Invited Commentary</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/5/549?rss=1">
<title><![CDATA[An Overview of CAM: Components and Clinical Uses]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/5/549?rss=1</link>
<description><![CDATA[
<p>Complementary and alternative medicine (CAM), more recently known as integrative health or integrative medicine, is a diverse field comprising numerous treatments and practitioners of various levels of training. This review defines several of the main CAM modalities and reviews some of the research relevant to their clinical application. The goal is to provide healthcare providers with a basic understanding of CAM to start the incorporation of proven treatments into their clinical practice as well as guide them to working with CAM providers; ultimately, such knowledge is a fundamental part of a collaborative approach to optimal patient health and wellness.</p>
]]></description>
<dc:creator><![CDATA[Kiefer, D., Pitluk, J., Klunk, K.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:04 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609342437</dc:identifier>
<dc:title><![CDATA[An Overview of CAM: Components and Clinical Uses]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>559</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>549</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/5/560?rss=1">
<title><![CDATA[The Metabolic Syndrome: Definition, Global Impact, and Pathophysiology]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/5/560?rss=1</link>
<description><![CDATA[
<p>The metabolic syndrome (MS) is a cluster of metabolic derangements that are associated with primary disturbances in adipose tissue. Abnormal visceral fat accumulates from physical inactivity and excess calories in genetically susceptible individuals. This increased adipocyte mass acts as an endocrine organ and communicates with other organ systems via increases in inflammatory cytokines. The resulting disorders define MS as increased waist circumference, decreased serum high-density lipoprotein, and increased serum triglyceride levels, hypertension, and insulin resistance. MS accounts for the majority of cardiovascular disease risk in the U.S. population. Dietary interventions, such as the Mediterranean diet, have been shown to improve these metabolic derangements. Many substances found in these diets are being investigated as specific therapies for MS, and when scientific substantiation is lacking, they may be considered as part of complementary and alternative medicine (CAM). However, as scientific evidence accumulates, these CAM treatments may become part of conventional medicine. This review will scrutinize the emerging evidence behind many, though not all, CAM treatments currently thought to target the various derangements found in MS.</p>
]]></description>
<dc:creator><![CDATA[Potenza, M. V., Mechanick, J. I.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:04 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609342436</dc:identifier>
<dc:title><![CDATA[The Metabolic Syndrome: Definition, Global Impact, and Pathophysiology]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>577</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>560</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/5/578?rss=1">
<title><![CDATA[Pediatric Asthma: An Integrative Approach to Care]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/5/578?rss=1</link>
<description><![CDATA[
<p>Asthma in children and young adults is a complex disease with many different phenotypic expressions. Diagnosis is often made based on history and lung function including measuring airway reversibility. However, in children younger than 6 years of age, the diagnosis is more difficult because many children wheeze in the first 4-6 years of life, especially with viral infections. For those children, asthma treatment is often started empirically. Those who go on to develop chronic asthma most likely have a genetic predisposition and exposure to various environmental factors resulting in chronic inflammation of the lower respiratory tract. There are established national guidelines for diagnosing and treating asthma in children and adults. For persistent asthma, it is recommended that medications be taken on a regular basis after identifying and avoiding environmental triggers. Because many factors play a role in developing asthma in children, many nonmedical approaches to asthma and asthma-like conditions have been promoted even when the diagnosis is at times uncertain. The nonmedical approaches and therapies are often referred to as complementary and alternative medicine (CAM). This review will discuss the conventional therapies recommended for children with asthma in addition to CAM therapies, some of which have supporting scientific evidence. Integrating conventional and CAM therapies can prove to be an effective way to treat pediatric asthma, a common and chronic childhood lung disorder. A case is provided to illustrate how such an integrative approach was used in the successful treatment of a child with moderate persistent asthma.</p>
]]></description>
<dc:creator><![CDATA[Mark, J. D.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:04 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609342446</dc:identifier>
<dc:title><![CDATA[Pediatric Asthma: An Integrative Approach to Care]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>588</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>578</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/5/589?rss=1">
<title><![CDATA[Complementary and Alternative Medications for Women's Health Issues]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/5/589?rss=1</link>
<description><![CDATA[
<p>Women often seek alternative treatment options such as herbs, dietary supplements, and vitamins and minerals to treat women&rsquo;s health issues across the lifespan. Women may use complementary and alternative supplements for dysmenorrhea, premenstrual syndrome, infertility, nausea and vomiting during pregnancy, and symptoms of menopause. In general, there is a deficit of well-designed, randomized, controlled trials to evaluate the efficacy and safety of complementary and alternative medicine for these indications, which makes it difficult to provide evidence-based recommendations. This review outlines the evidence for efficacy and safety that is currently available for dietary supplement use by women to manage health conditions specific to the female patient.</p>
]]></description>
<dc:creator><![CDATA[Lloyd, K. B., Hornsby, L. B.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:04 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609343001</dc:identifier>
<dc:title><![CDATA[Complementary and Alternative Medications for Women's Health Issues]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>608</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>589</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/5/609?rss=1">
<title><![CDATA[CAM and Respiratory Disease]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/5/609?rss=1</link>
<description><![CDATA[
<p>Complementary and alternative medicine is used commonly for respiratory diseases. This review summarizes data that identify potential links between dietary intake and asthma, and results of interventional trials of herbal substances for the treatment of asthma, chronic obstructive pulmonary disease, and acute bronchitis.</p>
]]></description>
<dc:creator><![CDATA[Sorkness, R. L.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:04 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609342438</dc:identifier>
<dc:title><![CDATA[CAM and Respiratory Disease]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>615</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>609</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/5/616?rss=1">
<title><![CDATA[Formulation, Stability, and Administration of Parenteral Nutrition With New Lipid Emulsions]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/5/616?rss=1</link>
<description><![CDATA[
<p>Intravenous lipid emulsions (IVLE) are an important source of energy and essential fatty acids and their incorporation into pediatric and adult parenteral nutrition (PN) regimens has revolutionized nutrition therapy. However, their clinical use has not been without risk, and will continue to remain so because of the intravenous route of administration. Pharmaceutical and microbiological concerns are centered around the methods of compounding all-in-one (AIO) admixtures, but these can be largely minimized with today&rsquo;s technologies and advanced understanding of aseptic principles. Modern lipid products, based on olive, coconut, and/or fish oils, have demonstrable formulation and clinical benefits over traditional soybean and safflower IVLE and, when combined in the new multi-chamber bags, can also offer improvements in stability and safety. This review outlines the rationale for different lipid formulations in PN admixtures, reviews the factors influencing stability and efficacy of lipid-based AIO regimens and evaluates some technologies for minimizing peroxidation and maximizing stability of AIO admixtures.</p>
]]></description>
<dc:creator><![CDATA[Hardy, G., Puzovic, M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609342445</dc:identifier>
<dc:title><![CDATA[Formulation, Stability, and Administration of Parenteral Nutrition With New Lipid Emulsions]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>625</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>616</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/5/626?rss=1">
<title><![CDATA[Hyperglycemic Events in Non-Intensive Care Unit Patients Receiving Parenteral Nutrition]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/5/626?rss=1</link>
<description><![CDATA[
<sec id="section1-0884533609339069"><st>Background:</st>
<p>Evidence supports the benefits of tight glycemic control in many patient populations. There is no consensus on appropriate targets for blood glucose (BG) values in patients receiving parenteral nutrition (PN). Characterization of the frequency of BG abnormalities is necessary to identify effective strategies to improve glycemic control in this patient population.</p>
</sec>
<sec id="section2-0884533609339069"><st>Methods:</st>
<p>Data were retrospectively collected over a 2-month period from 50 non&ndash;intensive care unit (ICU) patients who received PN. Frequencies of abnormal BG (defined as BG outside the range of 2 criteria: 80-200 mg/dL and 100-150 mg/dL) were determined. An event of hyperglycemia was defined as the 48-hour period following a BG value outside of 80-200 mg/dL. Each event was evaluated for resolution within 48 hours of the triggering BG value.</p>
</sec>
<sec id="section3-0884533609339069"><st>Results:</st>
<p>Hyperglycemia (at least 1 BG value &gt;200 mg/dL) occurred in 22 patients (44%). Of the 1738 BG values measured, 8.7% were &gt;200 mg/dL, resulting in 1.4 events of hyperglycemia per patient. The average blood glucose value for the population was 140 mg/dL. The frequency of hyperglycemia and hypoglycemia increased substantially, with only 1 patient having a PN course with normoglycemia using the 100-150 mg/dL criterion.</p>
</sec>
<sec id="section4-0884533609339069"><st>Conclusion:</st>
<p>The frequency of hyperglycemia in non-ICU PN patients is high according to either evaluation criterion. A method is described for using events to characterize hyperglycemia, which may be more useful than traditional methods in clinical decision making and identification of need for process improvements. These data suggest the need to develop better methods for BG control in non-ICU PN patients.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Pleva, M., Mirtallo, J. M., Steinberg, S. M.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339069</dc:identifier>
<dc:title><![CDATA[Hyperglycemic Events in Non-Intensive Care Unit Patients Receiving Parenteral Nutrition]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>634</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>626</prism:startingPage>
<prism:section>Clinical Observation</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/5/635?rss=1">
<title><![CDATA[Enteral Nutrition in Nursing Home Residents: A 5-Year (2001-2005) Epidemiological Analysis]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/5/635?rss=1</link>
<description><![CDATA[
<sec id="section1-0884533609342439"><st>Background.</st>
<p>Despite controversy and increasing use of enteral nutrition (EN) among elderly people, descriptive population-based data are scarce. The aim of this study was to evaluate the epidemiological data of nursing home residents (NHRs) who received EN in a northeast area of Italy.</p>
</sec>
<sec id="section2-0884533609342439"><st>Methods.</st>
<p>All NHRs referred to our Nutrition Service for EN between 2001 and 2005 were enrolled. Data collected at EN initiation included age, gender, underlying disease, Karnofsky index, type of enteral access device, presence of pressure ulcers, weight, body mass index, and daily enteral intake. The outcomes considered were patient survival and duration of therapy.</p>
</sec>
<sec id="section3-0884533609342439"><st>Results.</st>
<p>The 482 NHRs (130 males; 352 females) received EN. The mean incidence (cases/million population/year) and prevalence (cases/million population) were 223.4 and 279.4, respectively. An average of 6.6% of all NHRs were tube fed. EN was prescribed for the following conditions: 27.7% cerebrovascular accident, 54.6% neurodegenerative disease, 2.7% head and neck cancer, 1.2% abdominal cancer, 1.3% head trauma, 4.8% congenital disease, 7.7% other. Almost all patients had a Karnofsky index &le;50; 42.3% of patients had pressure ulcers. The median duration of EN was 296 days and the median overall survival was 411 days.</p>
</sec>
<sec id="section4-0884533609342439"><st>Conclusions.</st>
<p>NHRs receiving EN were mainly afflicted with neurodegenerative and cerebrovascular diseases, functional impairments, and a high incidence of pressure sores. The mortality rate was low compared with others reported in literature. The low EN use among NHRs in our study may suggest a limited use in advanced dementia and at end-stage of life.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Morello, M., Marcon, M. L., Laviano, A., Giometto, M., Baruffi, C., Zulian, E., Cenerelli, P., Faronato, P., Tessarin, M., Conte, A., Paccagnella, A.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609342439</dc:identifier>
<dc:title><![CDATA[Enteral Nutrition in Nursing Home Residents: A 5-Year (2001-2005) Epidemiological Analysis]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>641</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>635</prism:startingPage>
<prism:section>Clinical Observation</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/642?rss=1">
<title><![CDATA[Vitamin D: A D-Lightful Health Supplement]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/642?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mullin, G. E., Turnbull, L., Kines, K., Mullin, G. E.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609343938</dc:identifier>
<dc:title><![CDATA[Vitamin D: A D-Lightful Health Supplement]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>644</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>642</prism:startingPage>
<prism:section>CAM Corner</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/645?rss=1">
<title><![CDATA[Article Commentary: Higher Dose of Docosahexaenoic Acid in the Neonatal Period Improves Visual Acuity of Preterm Infants: Results of a Randomized Controlled Trial]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/645?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Slicker, J.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609343924</dc:identifier>
<dc:title><![CDATA[Article Commentary: Higher Dose of Docosahexaenoic Acid in the Neonatal Period Improves Visual Acuity of Preterm Infants: Results of a Randomized Controlled Trial]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>646</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>645</prism:startingPage>
<prism:section>Current Literature</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/647?rss=1">
<title><![CDATA[Article Commentary: Efficacy of Glutamine-Supplemented Parenteral Nutrition on Short-Term Survival Following Allo-SCT: A Randomized Study]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/647?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Phillips, S. K.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609343923</dc:identifier>
<dc:title><![CDATA[Article Commentary: Efficacy of Glutamine-Supplemented Parenteral Nutrition on Short-Term Survival Following Allo-SCT: A Randomized Study]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>648</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>647</prism:startingPage>
<prism:section>Current Literature</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/649?rss=1">
<title><![CDATA[Book Review: Integrating Therapeutic and Complementary Nutrition]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/649?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ireton-Jones, C.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609343939</dc:identifier>
<dc:title><![CDATA[Book Review: Integrating Therapeutic and Complementary Nutrition]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>649</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>649</prism:startingPage>
<prism:section>Book Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/650?rss=1">
<title><![CDATA[Book Review: Nutrition and Gastrointestinal Disease]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/650?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ireton-Jones, C.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339036</dc:identifier>
<dc:title><![CDATA[Book Review: Nutrition and Gastrointestinal Disease]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>650</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>650</prism:startingPage>
<prism:section>Book Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/651?rss=1">
<title><![CDATA[A Commentary on the Construction of Weight Velocity Charts]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/651?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Zemel, B. S.]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609342081</dc:identifier>
<dc:title><![CDATA[A Commentary on the Construction of Weight Velocity Charts]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>653</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>651</prism:startingPage>
<prism:section>Letter to the Editor</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/654?rss=1">
<title><![CDATA[Erratum]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/654?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609349329</dc:identifier>
<dc:title><![CDATA[Erratum]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>654</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>654</prism:startingPage>
<prism:section>Errata</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/5/655?rss=1">
<title><![CDATA[Erratum]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/5/655?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Mon, 19 Oct 2009 11:35:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609349332</dc:identifier>
<dc:title><![CDATA[Erratum]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>655</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>655</prism:startingPage>
<prism:section>Errata</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/4/430?rss=1">
<title><![CDATA[What Does it Mean to "Own Feeding Tubes"?]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/4/430?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[McClave, S. A.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:45 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339896</dc:identifier>
<dc:title><![CDATA[What Does it Mean to "Own Feeding Tubes"?]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>432</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>430</prism:startingPage>
<prism:section>On My Mind: An Opportunity to Dialogue with A.S.P.E.N. President Stephen A. McClave</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/4/433?rss=1">
<title><![CDATA[Change Is in the Wind]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/4/433?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Van Way, C. W.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339035</dc:identifier>
<dc:title><![CDATA[Change Is in the Wind]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>435</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>433</prism:startingPage>
<prism:section>Invited Commentaries</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/4/436?rss=1">
<title><![CDATA[Innovation, Persistence, and Proficiency in Parenteral Nutrition]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/4/436?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Dudrick, S. J.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609341164</dc:identifier>
<dc:title><![CDATA[Innovation, Persistence, and Proficiency in Parenteral Nutrition]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>440</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>436</prism:startingPage>
<prism:section>Invited Commentaries</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/441?rss=1">
<title><![CDATA[Compounding Parenteral Nutrition: Reducing the Risks]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/441?rss=1</link>
<description><![CDATA[
<p>Compounding parenteral nutrition, either manually or with an automated
compounding device, requires aseptic conditions and trained personnel. The
revised version of United States Pharmacopeia Chapter &lt;797&gt; is a
comprehensive document that describes standards and procedures to minimize the
risk of contamination of compounded parenteral products. The chapter includes
evidence-based instructions for pharmacy design, washing, garbing, cleaning,
quality assurance, and personnel training and evaluation designed to improve
compounding practices in all pharmacies that compound parenteral products.
Because parenteral nutrition is a compounded product mixed from multiple
additives, it is important to maintain these standards, especially when using
an automated compounding device. This article is an overview of United States
Pharmacopeia Chapter &lt;797&gt;, with special emphasis on parenteral
nutrition.</p>
]]></description>
<dc:creator><![CDATA[Curtis, C., Sacks, G. S.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339070</dc:identifier>
<dc:title><![CDATA[Compounding Parenteral Nutrition: Reducing the Risks]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>446</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>441</prism:startingPage>
<prism:section>Invited Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/447?rss=1">
<title><![CDATA[A Nutrition Support Service Web Application to Manage Patients Receiving Parenteral Nutrition]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/447?rss=1</link>
<description><![CDATA[
<p>Parenteral nutrition (PN) is a complex therapy that requires expertise and
experience to avoid errors in prescribing and management. Because of care
coordination issues, one medical center has developed and implemented a
Web-based application to manage PN patients. PN orders have already been
programmed into the physician order entry system, but the nutrition support
service (NSS) consult and daily PN management have been performed using paper
forms. The Web system is developed for ease of use by clinicians and
accessibility at any computer within the medical center. The database consists
of 12 tables interrelated by the patient medical record number, admission
number, or location. The NSS consult is the main table used to navigate to the
other tables. Update of the laboratory and PN formula table must be done
through the consult table. The system is compliant with the Health Insurance
Portability and Accountability Act guidelines, and has been developed so that
the forms that are required to be placed in the patient's permanent record can
be printed. Demographic information and laboratory data are automatically
populated via a link to the medical center's medication management system. At
present, there are 1393 patients in the database and 21,000 pages are viewed
each month during daily PN management by clinicians. Data can be easily
retrieved for management reports. Data elements can be exported directly from
the database to worksheets. This function has been used for projects designed
to improve the efficiency of this PN system.</p>
]]></description>
<dc:creator><![CDATA[Mirtallo, J. M., Hawksworth, K., Payne, B.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339068</dc:identifier>
<dc:title><![CDATA[A Nutrition Support Service Web Application to Manage Patients Receiving Parenteral Nutrition]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>458</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>447</prism:startingPage>
<prism:section>Clinical Observation</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/459?rss=1">
<title><![CDATA[Commercial Premixed Parenteral Nutrition: Is It Right for Your Institution?]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/459?rss=1</link>
<description><![CDATA[
<p>Two-compartment premixed parenteral nutrition (PN) products are heavily
promoted in the United States. These products may present safety advantages
over PN solutions mixed by a local pharmacy, although clinical data to support
this assertion are scarce. Multicompartment products can be labor-saving for
pharmacy and therefore may be cost-effective for some institutions. Before
adopting such products for use, an institution must determine that
standardized PN solutions are acceptable for many or most of their patients
compared with customized PN compounded specifically for individual patients. A
larger selection of premixed products is available in Europe and some other
parts of the world compared with the United States. Availability of a broader
selection of products in the United States, including 3-compartment bags and a
wider range of macronutrient concentrations and volumes, may make the use of
such products more desirable in the future.</p>
]]></description>
<dc:creator><![CDATA[Miller, S. J.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339067</dc:identifier>
<dc:title><![CDATA[Commercial Premixed Parenteral Nutrition: Is It Right for Your Institution?]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>469</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>459</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/470?rss=1">
<title><![CDATA[Intradialytic Parenteral Nutrition and Intraperitoneal Nutrition]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/470?rss=1</link>
<description><![CDATA[
<p>Intradialytic parenteral nutrition and intraperitoneal nutrition are
methods to provide supplemental nutrition support to patients with chronic
kidney disease (also referred to as end-stage renal disease) while they are
receiving dialytic therapy. There has been considerable controversy over
indications and benefits of intradialytic parenteral nutrition and
intraperitoneal nutrition. A major stumbling block had been problematic
reimbursement for the therapy under Medicare. Medicare Part D has alleviated
some of the reimbursement obstacles and has increased interest in reexamining
the benefits and burdens of supplemental nutrition support therapies for
patients receiving dialysis.</p>
]]></description>
<dc:creator><![CDATA[Fuhrman, M. P.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339072</dc:identifier>
<dc:title><![CDATA[Intradialytic Parenteral Nutrition and Intraperitoneal Nutrition]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>480</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>470</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/481?rss=1">
<title><![CDATA[Pediatric Parenteral Nutrition: Putting the Microscope on Macronutrients and Micronutrients]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/481?rss=1</link>
<description><![CDATA[
<p>Parenteral nutrition can be a life-saving therapy, but its benefits need to
be balanced with a unique set of risks and complications. Methods of practice
vary because there is a dearth of research in the area of pediatric parenteral
nutrition. This article reviews the available literature on parenteral
nutrition in children and provides suggestions on prevention and management of
parenteral nutrition&ndash;associated liver disease. Some of the issues
discussed in this article include glucose infusion rates, cycling of
parenteral nutrition, copper and manganese toxicity, and the provision of
glutamine, selenium, and carnitine.</p>
]]></description>
<dc:creator><![CDATA[Slicker, J., Vermilyea, S.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339073</dc:identifier>
<dc:title><![CDATA[Pediatric Parenteral Nutrition: Putting the Microscope on Macronutrients and Micronutrients]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>486</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>481</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/487?rss=1">
<title><![CDATA[Fish Oil Lipid Emulsions and Immune Response: What Clinicians Need to Know]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/487?rss=1</link>
<description><![CDATA[
<p>Current evidence indicates that -3 polyunsaturated fatty acids
(PUFAs), particularly eicosapentaenoic acid and docosahexaenoic acid found in
fish oil, can prevent the development of inflammatory diseases by affecting
different steps of the immune response. The capacity of -3 PUFAs to
modulate synthesis of eicosanoids, activity of nuclear receptor and nuclear
transcription factors, and production of resolvins may also mitigate
inflammatory processes already present. Parenteral infusion of -3 PUFAs
is advantageous, particularly in severely ill patients, because the fatty
acids are rapidly incorporated by cells. In addition, when fatty acids are
given parenterally, there are no losses from digestion and absorption as there
are with enteral infusion. Recently, lipid emulsions enriched with -3
fish oil have been introduced as a component of parenteral nutrition.
Currently, there is one lipid emulsion that contains only fish oil; it is
infused together with conventionally used lipid emulsions. Other commercially
available lipid emulsions contain fish oil in a fat mixture; one contains 10%
fish oil and another 15% fish oil. Relevant experimental and clinical data
from studies evaluating fish oil lipid emulsions are discussed in the present
review. Administration of fish oil lipid emulsion, when compared with soybean
oil lipid emulsion (rich in -6 PUFA), decreases the length of hospital
and intensive care unit stay in surgical patients.</p>
]]></description>
<dc:creator><![CDATA[Waitzberg, D. L., Torrinhas, R. S.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609339071</dc:identifier>
<dc:title><![CDATA[Fish Oil Lipid Emulsions and Immune Response: What Clinicians Need to Know]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>499</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>487</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/500?rss=1">
<title><![CDATA[Development and Implementation of an Audit Tool for Quality Control of Parenteral Nutrition]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/500?rss=1</link>
<description><![CDATA[
<p><I>Background:</I> The aim of this article is to describe the development
of a quality control methodology applied to patients receiving parenteral
nutrition (PN) and to present the results obtained over the past 10 years.
<I>Development of the audit tool:</I> In 1995, a total of 13 PN quality
criteria and their standards were defined based on literature and past
experiences. They were applied during 5 different 6-month audits carried out
in subsequent years. According to the results of each audit, the criteria with
lower validity were eliminated, while others were optimized and new criteria
were introduced to complete the monitoring of other areas not previously
examined. Currently, the quality control process includes 22 quality criteria
and their standards that examine the following 4 different areas: (1)
indication and duration of PN; (2) nutrition assessment, adequacy of the
nutrition support, and monitoring; (3) metabolic and infectious complications;
and (4) global efficacy of the nutrition support regimen. The authors describe
the current definition of each criterion and present the results obtained in
the 5 audits performed. In the past year, 9 of the 22 criteria reached the
predefined standards. The areas detected for further improvements were:
indication for PN, nutrition assessment, and management of catheter
infections. <I>Conclusions:</I> The definition of quality criteria and their
standards is an efficient method of providing a qualitative and quantitative
analysis of the clinical care of patients receiving PN. It detects areas for
improvement and assists in developing a methodology to work efficiently.</p>
]]></description>
<dc:creator><![CDATA[Garcia-Rodicio, S., Abajo, C., Godoy, M., Catala, M. A.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335123</dc:identifier>
<dc:title><![CDATA[Development and Implementation of an Audit Tool for Quality Control of Parenteral Nutrition]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>507</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>500</prism:startingPage>
<prism:section>Techniques and Procedures</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/508?rss=1">
<title><![CDATA[Fish Oil Supplementation Lowers C-Reactive Protein Levels Independent of Triglyceride Reduction in Patients With End-Stage Renal Disease]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/508?rss=1</link>
<description><![CDATA[
<p><I>Background:</I> Inflammation has been identified as a marker for
cardiovascular disease. The purpose of this study is to examine the effects of
fish oil fatty acid supplementation on C-reactive protein (CRP) levels.
<I>Methods:</I> The study uses a double-blind, permuted-randomized, and
placebo-controlled experimental protocol. Patients are randomly placed into a
fish oil group or a control group. Thirty-three patients in the experimental
and control groups ingest 2 soft-gel pills (1 g each) of fish oil supplements
containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) or
placebo at each meal. Patients follow the supplementation protocol for 6
months. Analysis of variance (ANOVA) is used to measure pretest and posttest
differences in the variable of interest. A Kolmogorov-Smirnov test for
normality is used to test whether CRP levels are normally distributed.
<I>Results:</I>The Kolmogorov-Smirnov test for CRP finds a <I>P</I> value
of .273 (KS = .997), revealing that the distribution is normal. ANOVA reveals
no statistically significant difference between groups at baseline for CRP
(<I>F</I> = 4.118, <I>P</I> = .053). ANOVA reveals a significant main
effect (<I>F</I> = 4.29, <I>P</I> = .048) for CRP, with the EPA/DHA group
having a significant change in values from pretest (16 mg/dL, standard
deviation [SD] = 13.80) to posttest (10.22 mg/dL, SD = 7.87). The placebo
group's CRP levels do not change significantly from pretest (13.37, standard
deviation [SD] = 7.94) to posttest (13.67, SD = 7.07). An observed power
calculation using Cohen's D with a computed  of .05 is .588.
<I>Conclusions:</I> The study demonstrates that consuming 960 mg/d of EPA
and 600 mg/d of DHA can lower CRP.</p>
]]></description>
<dc:creator><![CDATA[Bowden, R. G., Wilson, R. L., Deike, E., Gentile, M.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335376</dc:identifier>
<dc:title><![CDATA[Fish Oil Supplementation Lowers C-Reactive Protein Levels Independent of Triglyceride Reduction in Patients With End-Stage Renal Disease]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>512</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>508</prism:startingPage>
<prism:section>Clinical Research</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/513?rss=1">
<title><![CDATA[A Reduced Abbreviated Indirect Calorimetry Protocol Is Clinically Acceptable for Use in Spontaneously Breathing Patients With Traumatic Brain Injury]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/513?rss=1</link>
<description><![CDATA[
<p>A steady state should be established when using indirect calorimetry to
assess resting energy expenditure, reduce error, and improve the validity of
the measurement. Steady-state criteria are often rigorous and difficult to
achieve in hospitalized patients, particularly in patients recovering from
traumatic brain injury. This study aimed to assess whether reducing the
timeframe for steady-state conditions to 2, 3, or 4 minutes when using
indirect calorimetry was significantly different from the widely accepted
5-minute steady-state protocol in patients recovering from traumatic brain
injury. Indirect calorimetry using an open-circuit calorimeter was used to
measure resting energy expenditure in 20 spontaneously breathing patients with
traumatic brain injury. Each patient underwent repeated measurements once per
day at various stages of his or her recovery. Bland-Altman methods comparison
was used for statistical analysis. In total, 124 measurements were recorded,
of which 59% met 5-minute, 70% met 4-minute, 76% met 3-minute, and 84% met
2-minute steady-state conditions. Mean within-patient coefficient of variation
was 13% (range, 0%-35%). Agreement at the &plusmn;10% level using Bland-Altman
plots was 100% for a 4-minute steady-state protocol, 96% for a 3-minute
protocol, and 90% using a 2-minute protocol. A 4-minute or 3-minute
abbreviated steady-state indirect calorimetry protocol is clinically
acceptable to measure resting energy expenditure in spontaneously breathing
patients with a traumatic brain injury.</p>
]]></description>
<dc:creator><![CDATA[McEvoy, C., Cooke, S. R., Young, I. S.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335308</dc:identifier>
<dc:title><![CDATA[A Reduced Abbreviated Indirect Calorimetry Protocol Is Clinically Acceptable for Use in Spontaneously Breathing Patients With Traumatic Brain Injury]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>519</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>513</prism:startingPage>
<prism:section>Clinical Research</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/4/520?rss=1">
<title><![CDATA[Nutrition Support in Surgical Oncology]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/4/520?rss=1</link>
<description><![CDATA[
<p>This review article, the second in a series of articles to examine the
American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Guidelines
for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric
Patients, evaluates the evidence related to the use of nutrition support in
surgical oncology patients. Cancer patients develop complex nutrition issues.
Nutrition support may be indicated in malnourished cancer patients undergoing
surgery, depending on individual patient characteristics. As with the first
article in this series, this article provides background concerning nutrition
issues in cancer patients, as well as discusses the role of nutrition support
in the care of surgical cancer patients. The goal of this review is to enrich
the discussion contained in the clinical guidelines as they relate to
recommendations made for surgical patients, cite the primary literature more
completely, and suggest updates to the guideline statements in light of
subsequently published studies.</p>
]]></description>
<dc:creator><![CDATA[Huhmann, M. B., August, D. A.]]></dc:creator>
<dc:date>Wed, 15 Jul 2009 13:51:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335375</dc:identifier>
<dc:title><![CDATA[Nutrition Support in Surgical Oncology]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>526</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>520</prism:startingPage>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/3/297?rss=1">
<title><![CDATA[The Evolving Rationale for Early Enteral Nutrition Based on Paradigms of Multiple Organ Failure: A Personal Journey]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/3/297?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Moore, F. A., Moore, E. E.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609336604</dc:identifier>
<dc:title><![CDATA[The Evolving Rationale for Early Enteral Nutrition Based on Paradigms of Multiple Organ Failure: A Personal Journey]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>304</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>297</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/305?rss=1">
<title><![CDATA[The Physiologic Response and Associated Clinical Benefits From Provision of Early Enteral Nutrition]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/305?rss=1</link>
<description><![CDATA[
<p>Provision of enteral nutrition (EN) to critically ill patients early upon
admission to the intensive care unit exerts a beneficial physiologic effect
that downregulates systemic immune responses, reduces oxidative stress, and
improves patient outcome. Adding specific pharmaconutrient agents to EN in
certain patient populations has a synergistic effect, magnifying the degree of
this favorable physiologic response. In contrast, failure to provide enteral
nutrients creates a physiologic profile that exacerbates oxidative stress and
increases the systemic inflammatory response syndrome. Unfortunately,
parenteral nutrition (PN) in the form and manner currently provided in North
America does not appear to mimic the same physiologic response seen with EN.
In the future, use of alternative fuel sources, steps to promote better
tolerance of EN, and innovative strategies for delivery of both EN and PN may
serve to further enhance the physiologic effect of nutrition therapy and to
achieve even greater improvement in patient outcome.</p>
]]></description>
<dc:creator><![CDATA[McClave, S. A., Heyland, D. K.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335176</dc:identifier>
<dc:title><![CDATA[The Physiologic Response and Associated Clinical Benefits From Provision of Early Enteral Nutrition]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>315</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>305</prism:startingPage>
<prism:section>Clinical Controversies</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/316?rss=1">
<title><![CDATA[Enteral Nutrition: A Hard Look at Some Soft Evidence]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/316?rss=1</link>
<description><![CDATA[
<p>Those who read the medical literature should understand the principles of
evidence-based medicine. Even randomized trials can contain design or
interpretative flaws that allow bias to produce, or exaggerate the size of,
beneficial effects. Such problems beset the literature of enteral nutrition
(EN). Investigators who have compared EN with parenteral nutrition (PN) have
alleged that EN produces fewer adverse events, but such studies do not assess
the absolute value of either therapy, and data exist suggesting that PN causes
net harm. Trials comparing EN with no nutrition therapy have not yielded
convincing evidence of efficacy because the study designs have failed to use
methods to prevent bias from interfering with the observations. This same
problem exists with trials that have assessed volitional feeding programs (eg,
oral supplements). Thus, although systematic reviews have alleged that EN
benefits patients undergoing surgery, patients in the critical care unit,
patients with liver disease, and patients with pancreatitis, the presence of
bias limits any positive conclusions. As a manifestation of this issue, when
the various trials are separated into studies with high and low risks of bias,
those with low risks have not shown any benefit. EN has been accepted and
implemented despite the lack of convincing scientific support of efficacy.</p>
]]></description>
<dc:creator><![CDATA[Koretz, R. L.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335378</dc:identifier>
<dc:title><![CDATA[Enteral Nutrition: A Hard Look at Some Soft Evidence]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>324</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>316</prism:startingPage>
<prism:section>Clinical Controversies</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/325?rss=1">
<title><![CDATA[Enteral Feeding Misconnections: An Update]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/325?rss=1</link>
<description><![CDATA[
<p>Enteral misconnections are defined as inadvertent connections between
enteral feeding systems and nonenteral systems such as intravascular lines,
peritoneal dialysis catheters, tracheostomy tube cuffs, medical gas tubing,
and so on. Sentinel event data and causative factors are outlined along with
potential solutions to prevent such medical errors. The solutions can be
grouped into 3 areas: (1) education, awareness, and human factors; (2)
purchasing strategies; and (3) design changes. Updates on safety innovations
and programs are presented.</p>
]]></description>
<dc:creator><![CDATA[Guenter, P., Hicks, R. W., Simmons, D.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335174</dc:identifier>
<dc:title><![CDATA[Enteral Feeding Misconnections: An Update]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>334</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>325</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/335?rss=1">
<title><![CDATA[Implementation of the Enteral Nutrition Practice Recommendations]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/335?rss=1</link>
<description><![CDATA[
<p>In developing the evidence-based <I>Enteral Nutrition Practice
Recommendations</I>, the American Society for Parenteral and Enteral
Nutrition (A.S.P.E.N.) formed a task force to address the many aspects of
safety in the delivery and provision of enteral nutrition support. This
recently published document provides healthcare professionals with
recommendations that are derived from evidence-based practice. The development
and use of clinical practice guidelines (CPGs) is a recent, significant
contribution for the dissemination of evidence-based medicine. This involves
the review of scientific literature along with clinical skill and knowledge to
generate specific recommendations assisting healthcare providers and patients
with decisions regarding appropriate healthcare. A primary opportunity to
improve patient outcomes will come from the effective delivery of existing
therapies rather than from the new development of treatment modalities.
Compliance with CPGs is challenging because it depends on a variety of
factors. Both general and specific strategies have been devised with the
expansion of the new discipline of implementation science. The high degree of
evidence now available in medicine gives clinicians more opportunity to
improve patient outcomes and quality of care. It remains for clinicians to
evaluate their institutional mission and goals, and to investigate those CPGs
appropriate to improve patient care in that setting.</p>
]]></description>
<dc:creator><![CDATA[Brantley, S. L.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335311</dc:identifier>
<dc:title><![CDATA[Implementation of the Enteral Nutrition Practice Recommendations]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>343</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>335</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/344?rss=1">
<title><![CDATA[Enteral Nutrition Formulas: Which Formula Is Right for Your Adult Patient?]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/344?rss=1</link>
<description><![CDATA[
<p>In the last few decades, there has been tremendous advancement in the area
of enteral nutrition formulas. Enteral nutrition makes it possible to provide
important substrates for those who cannot or will not meet daily requirements
via oral intake but who have an intact digestive system. Numerous enteral
nutrition formulas are currently available, with a large portion of them
targeting specific disease conditions, thus making it a daunting task at times
for a clinician to sort through all the possibilities and decide on the most
appropriate formula. This review provides a close examination of various
enteral formula categories and presents proposed mechanisms of specialized
ingredients, followed by a thorough evidence-based analysis of existing
literature before making recommendations for the various enteral formula
categories.</p>
]]></description>
<dc:creator><![CDATA[Chen, Y., Peterson, S. J.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335377</dc:identifier>
<dc:title><![CDATA[Enteral Nutrition Formulas: Which Formula Is Right for Your Adult Patient?]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>355</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>344</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/356?rss=1">
<title><![CDATA[Overview of Infant and Pediatric Formulas]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/356?rss=1</link>
<description><![CDATA[
<p>Because every child has individual needs, there are a variety of infant and
pediatric formulas from which to choose. Not only are there several categories
of formulas including milk protein-based, soy protein-based, hydrolyzed
protein, and amino acid-based, but there are differences between products
within each category. Research is being done in the area of formula design for
the prevention or treatment of disease. In this article, the authors review
types of formulas and their indications for use for infants and children, and
review current literature on formula trends.</p>
]]></description>
<dc:creator><![CDATA[Joeckel, R. J., Phillips, S. K.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335309</dc:identifier>
<dc:title><![CDATA[Overview of Infant and Pediatric Formulas]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>362</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>356</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/363?rss=1">
<title><![CDATA[Enteral Nutrition Support of the Preterm Infant in the Neonatal Intensive Care Unit]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/363?rss=1</link>
<description><![CDATA[
<p>The delivery of a preterm baby is a nutrition emergency. Growth and the
accumulation of nutrient reserves are higher during the third trimester of
pregnancy than at any other time during the life cycle. Enteral nutrition is
the preferred mode of support and human milk the preferred source of enteral
nutrition. Human milk is highly digestible and contains many anti-infective
components, which confer a lower risk of infection. The mother of a preterm
infant requires education, equipment, and encouragement to successfully
initiate and sustain lactation. Human milk requires nutrient fortification to
meet the protein and mineral needs of the rapidly growing preterm infant.
Commercial human milk fortifiers are available. If human milk is unavailable
or the volume is insufficient, preterm formulas are available. Preterm
formulas have different sources of macronutrients and greater density of all
nutrients than formulas intended for term newborns. Preterm infants benefit
from early enteral feedings with slow but steady increases in feedings to
achieve full support. Infants born at &lt;35 weeks gestational age are
supported with tube feedings. A transition to feedings at the breast or to
bottle feedings is gradually made as the baby matures. Nutrient
recommendations specific to the preterm infant are available. Special products
and feeding strategies exist to respond to common medical conditions that can
complicate nutrition management. Optimal nutrition care of the preterm infant
offers the opportunity to improve outcomes for children.</p>
]]></description>
<dc:creator><![CDATA[Groh-Wargo, S., Sapsford, A.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335310</dc:identifier>
<dc:title><![CDATA[Enteral Nutrition Support of the Preterm Infant in the Neonatal Intensive Care Unit]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>376</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>363</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/377?rss=1">
<title><![CDATA[Approach to Enteral Feeding in the PICU]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/377?rss=1</link>
<description><![CDATA[
<p>The pediatric intensive care unit (PICU) environment poses unique
challenges to achieving enteral nutrition (EN) goals for the critically ill
child. Nutrition support in the PICU is often in conflict with the complexity
of care provided to acutely ill children. A significant proportion of eligible
patients do not receive optimal enteral nutrition for avoidable reasons. Early
institution of EN is recommended and the gastric route is preferred because of
ease of administration and reduced costs compared with the transpyloric route.
In patients with poor gastric emptying or in cases where a trial of gastric
feeding has failed, transpyloric or postpyloric feeding may be used to
decrease the risk of aspiration and to improve enteral feed tolerance.
However, there is no evidence of benefit for routine use of small bowel
feeding in all patients admitted to the PICU. The placement of blind
nasoenteric feeding tubes can be technically challenging, is not without
complications, and requires local expertise and experience for successful
placement and maintenance. A protocolized approach to selecting the optimal
route and advancing enteral feedings may optimize EN delivery. Institutional
practice guidelines based on consensus, available evidence, and national
guidelines may decrease time to reaching caloric goal, improve protein
balance, and potentially affect clinical outcomes. The rationale and
challenges to the delivery and maintenance of optimal EN, and strategies to
achieve optimal EN during critical illness, are discussed.</p>
]]></description>
<dc:creator><![CDATA[Mehta, N. M.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335175</dc:identifier>
<dc:title><![CDATA[Approach to Enteral Feeding in the PICU]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>387</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>377</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/388?rss=1">
<title><![CDATA[Systematic Review of Postdischarge Oral Nutritional Supplementation in Patients Undergoing GI Surgery]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/388?rss=1</link>
<description><![CDATA[
<p><I>Objective:</I> To determine whether nutritional supplementation
following hospital discharge in patients who undergo gastrointestinal (GI)
surgery is benefical in specific outcome measures. <I>Methods:</I> A
systematic review was conducted of randomized controlled trials comparing
nutritional supplements vs a "standard care" regimen given to
patients following discharge from hospital after GI surgery. Outcome measures
were weight change, quality of life, clinical complications, fatigue, and hand
grip strength. <I>Results:</I> Four studies were identified. Postdischarge
oral nutritional supplements were found to be safe and increased energy
intake, protein intake, and weight in patients after discharge from hospital.
The greatest gains in weight were seen in malnourished patients. Little
evidence was found that nutritional supplements reduce morbidity or improve
quality of life, fatigue, or hand-grip strength. Only one study was
methodologically adequate, and none were powered to detect differences in
clinical complications. <I>Conclusions:</I> In patients who undergo GI
surgery and receive nutritional supplements after discharge from hospital,
little evidence of clinical benefit was found, principally through lack of
robust data. All the studies were under-powered or not specifically designed
to show benefit during this period. It is recommended that nutritional
supplements be offered to malnourished patients or those at high risk of poor
dietary intake at discharge from hospital.</p>
]]></description>
<dc:creator><![CDATA[Lidder, P. G, Lewis, S., Duxbury, M., Thomas, S.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332175</dc:identifier>
<dc:title><![CDATA[Systematic Review of Postdischarge Oral Nutritional Supplementation in Patients Undergoing GI Surgery]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>394</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>388</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/395?rss=1">
<title><![CDATA[Senescent Swallowing: Impact, Strategies, and Interventions]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/395?rss=1</link>
<description><![CDATA[
<p>The risk for disordered oropharyngeal swallowing (dysphagia) increases with
age. Loss of swallowing function can have devastating health implications,
including dehydration, malnutrition, pneumonia, and reduced quality of life.
Age-related changes increase risk for dysphagia. First, natural, healthy aging
takes its toll on head and neck anatomy and physiologic and neural mechanisms
underpinning swallowing function. This progression of change contributes to
alterations in the swallowing in healthy older adults and is termed
<I>presbyphagia</I>, naturally diminishing functional reserve. Second,
disease prevalence increases with age, and dysphagia is a comorbidity of many
age-related diseases and/or their treatments. Sensory changes, medication,
sarcopenia, and age-related diseases are discussed herein. Recent findings
that health complications are associated with dysphagia are presented.
Nutrient requirements, fluid intake, and nutrition assessment for older adults
are reviewed relative to dysphagia. Dysphagia screening and the pros and cons
of tube feeding as a solution are discussed. Optimal intervention strategies
for elders with dysphagia ranging from compensatory interventions to more
rigorous exercise approaches are presented. Compelling evidence of improved
functional swallowing and eating outcomes resulting from active rehabilitation
focusing on increasing strength of head and neck musculature is provided. In
summary, although oropharyngeal dysphagia may be life threatening, so are some
of the traditional alternatives, particularly for frail, elderly patients.
Although the state of the evidence calls for more research, this review
indicates that the behavioral, dietary, and environmental modifications
emerging in this past decade are compassionate, promising, and, in many cases,
preferred alternatives to the always present option of tube feeding.</p>
]]></description>
<dc:creator><![CDATA[Ney, D. M., Weiss, J. M., Kind, A. J. H., Robbins, J.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332005</dc:identifier>
<dc:title><![CDATA[Senescent Swallowing: Impact, Strategies, and Interventions]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>413</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>395</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/414?rss=1">
<title><![CDATA[Reduced Incidence of Aspiration With Spoon-Thick Consistency in Stroke Patients]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/414?rss=1</link>
<description><![CDATA[
<p><I>Background:</I> Dysphagia and aspiration occur frequently in stroke
patients. The aim of the present study was to evaluate 2 consistencies (liquid
and spoon-thick/pudding-like) regarding the risk of aspiration and to
determine the usefulness of a bedside speech therapy assessment to predict
risk of aspiration. <I>Methods:</I> This randomized, crossover clinical
trial was carried out April to August 2001 at a university hospital. Sixty-one
inpatients diagnosed with acute phase or prior stroke received liquid and
spoon-thick (pudding-like) feeds during nasoendoscopy and bedside clinical
assessment. <I>Results:</I> Aspiration occured in only 3 patients with the
spoon-thick consistency vs 21 with the liquid consistency (relative risk =
0.13; 95% confidence interval = 0.04-0.39; <I>P</I> &lt; .001). The bedside
assessment had a sensitivity of 81% and a specificity of 70.8% to detect risk
of aspiration. <I>Conclusions:</I> The use of a spoon-thick consistency
reduced the risk of aspiration compared with the liquid consistency. Clinical
assessment was useful to predict aspiration, although the probability of
dysphagia in the presence of a negative clinical assessment (29%) is a reason
for concern.</p>
]]></description>
<dc:creator><![CDATA[Diniz, P. B., Vanin, G., Xavier, R., Parente, M. A.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533608329440</dc:identifier>
<dc:title><![CDATA[Reduced Incidence of Aspiration With Spoon-Thick Consistency in Stroke Patients]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>418</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>414</prism:startingPage>
<prism:section>Clinical Research</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/3/419?rss=1">
<title><![CDATA[Comment On: Nutritional Deficiencies After Roux-en-Y Gastric Bypass for Morbid Obesity Often Cannot be Prevented by Standard Multivitamin Supplementation]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/3/419?rss=1</link>
<description><![CDATA[
<p><I>Background:</I> Despite the increasing use of Rouxen-Y gastric bypass
(RYGBP) in the treatment of morbid obesity, data about postoperative
nutritional deficiencies and their treatment remain scarce.
<I>Objective:</I> The aim of this study was to evaluate the efficacy of a
standard multivitamin preparation in the prevention and treatment of
nutritional deficiencies in obese patients after RYGBP. <I>Design:</I> This
was a retrospective study of a 2-year follow-up of obese patients after RYGBP
surgery. Between the first and the sixth postoperative months, a standardized
multivitamin preparation was prescribed for all patients. Specific
requirements for additional substitutive treatments were systematically
assessed by a biologic workup at 3, 6, 9, 12, 18, and 24 months.
<I>Results:</I> A total of 137 morbidly obese patients (110 women and 27
men) were included. The mean (&plusmn;SD) age at the time of surgery was 39.9
&plusmn; 10.0 years, and the body mass index (in kg/m<sup>2</sup>) was 46.7
&plusmn; 6.5. Three months after RYGBP, 34% of these patients required at
least one specific supplement in addition to the multivitamin preparation. At
6 and 24 months, this proportion increased to 59% and 98%, respectively. Two
years after RYGBP, a mean amount of 2.9 &plusmn; 1.4 specific supplements had
been prescribed for each patient, including vitamin B-12, iron, calcium +
vitamin D, and folic acid. At that time, the mean monthly cost of the
substitutive treatment was $34.83. <I>Conclusion:</I> Nutritional
deficiencies are very common after RYGBP and occur despite supplementation
with the standard multivitamin preparation. Therefore, careful postoperative
follow-up is indicated to detect and treat those deficiencies. (<I>Am J Clin Nutr.</I> 2008;87:1128-33.)</p>
<p><b>Gasteyger C, Suter M, Gaillard RC, and Giusti V.</b></p>
]]></description>
<dc:creator><![CDATA[Trumpy, M. S.]]></dc:creator>
<dc:date>Fri, 29 May 2009 10:31:46 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609335122</dc:identifier>
<dc:title><![CDATA[Comment On: Nutritional Deficiencies After Roux-en-Y Gastric Bypass for Morbid Obesity Often Cannot be Prevented by Standard Multivitamin Supplementation]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>420</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>419</prism:startingPage>
<prism:section>Current Literature</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/2/175?rss=1">
<title><![CDATA[]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/2/175?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hasse, J. M.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609334537</dc:identifier>
<dc:title><![CDATA[]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>175</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>175</prism:startingPage>
<prism:section>Editor's Note</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/2/176?rss=1">
<title><![CDATA[Issues in Geriatric Nutrition]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/2/176?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Chernoff, R.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332007</dc:identifier>
<dc:title><![CDATA[Issues in Geriatric Nutrition]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>178</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>176</prism:startingPage>
<prism:section>Invited Commentary</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/179?rss=1">
<title><![CDATA[Micronutrients and Older Adults]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/179?rss=1</link>
<description><![CDATA[
<p>The aging population worldwide is increasing. Although many older adults
are living longer, healthier lives, aging is also associated with a variety of
physiologic and psychological changes that influence nutrition status and the
need for medical care. Many factors increase the risk for poor nutrient intake
among older adults. Suboptimal micronutrient intake for particular vitamins
and minerals is reported to be common.</p>
]]></description>
<dc:creator><![CDATA[Marian, M., Sacks, G.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332177</dc:identifier>
<dc:title><![CDATA[Micronutrients and Older Adults]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>195</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>179</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/196?rss=1">
<title><![CDATA[Home Care for the Elderly]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/196?rss=1</link>
<description><![CDATA[
<p>The increasing numbers of older (&gt;65 years) Americans will increase the
demand for home health services including support services (nursing, physical
therapy, occupational therapy, durable medical equipment, and respiratory
therapy), infusion therapies, palliative care, and hospice. The unique
characteristics and specific needs of this population must be addressed to
optimize patient outcomes. The American Society for Parenteral and Enteral
Nutrition has established standards for clinicians providing nutrition support
in the home and provides practice guidelines for nutrition support and
geriatrics. Certification in gerontological care is available for dietitians,
pharmacists, physicians, and nurses. The key to optimal care for older adults
is to find the confluence of expertise in nutrition support and
geriatrics.</p>
]]></description>
<dc:creator><![CDATA[Fuhrman, M. P.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332173</dc:identifier>
<dc:title><![CDATA[Home Care for the Elderly]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>205</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>196</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/206?rss=1">
<title><![CDATA[The Artificial Nutrition Debate: Still an Issue... After All These Years]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/206?rss=1</link>
<description><![CDATA[
<p>Debate over withdrawal or withholding of artificial nutrition appeared a
distant discussion until the furor over the Schiavo case and a Papal
Allocation reignited this ethical dilemma. The purpose of this article is to
provide a review of the bioethical opinion regarding artificial nutrition, as
published in the <I>Hastings Center Report</I> from 1971 until 2007. A
clinical and religious history of the evolution and use of artificial
nutrition prefaces the review containing common themes and categories framed
within a chronology of bioethical and legal events. Finally, an interpretative
philosophical discussion is offered on the resurgence of the ethical dilemma
concerning withdrawal or withholding of artificial nutrition. Through a
combination of classic content analysis and grounded theory, 8 inductively
derived categories emerged from a sample of 63 articles/letters with a primary
focus on artificial nutrition, enteral nutrition or parenteral nutrition.
These categories included illness/treatment trajectory, personhood, family,
provider, cost, religion, legal, and ethics and morality. In more than 35
years, surprisingly little has changed with regard to withdrawal or
withholding of artificial nutrition. As the Schiavo case revealed, despite a
sense in bioethics of a firm consensus about handling the withdrawal of food
and water, many are still searching for answers to this dilemma.</p>
]]></description>
<dc:creator><![CDATA[Monturo, C.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332089</dc:identifier>
<dc:title><![CDATA[The Artificial Nutrition Debate: Still an Issue... After All These Years]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>213</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>206</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/214?rss=1">
<title><![CDATA[Tube Feeding in Patients With Dementia: Where Are We?]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/214?rss=1</link>
<description><![CDATA[
<p>Dementia is a common diagnosis and accounts for significant morbidity and
mortality. In the United States, the practice of medicine commonly dictated
that dementia patients with dysphagia should receive a feeding tube. A review
of the evidence in 1999 was completed to understand the validity of the
premise of an improvement in a dementia patient's survival, quality of life,
malnutrition, and comorbid diseases with tube feeding. The available
literature reviewed was sparse. The retrospective and prospective
observational studies noted no improvement in the above-mentioned outcomes in
dementia patients with the use of tube feeding. Interestingly, a recent
retrospective review denoted that dementia patients had no worse survival than
patients with other diseases receiving a feeding tube and tube feedings. A
prospective study comparing tube feeding to hand feeding in the dementia
population is sorely needed.</p>
]]></description>
<dc:creator><![CDATA[DeLegge, M. H.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332006</dc:identifier>
<dc:title><![CDATA[Tube Feeding in Patients With Dementia: Where Are We?]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>216</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>214</prism:startingPage>
<prism:section>Pivotal Paper</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/217?rss=1">
<title><![CDATA[Anemia After Bariatric Surgery: More Than Just Iron Deficiency]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/217?rss=1</link>
<description><![CDATA[
<p>Bariatric surgery for morbid obesity is rapidly gaining popularity.
Restrictive and/or malabsorptive surgical interventions result in dramatic
weight loss with significantly decreased obesity-related morbidity and
mortality. Anemia, which may affect as many as two-thirds of these patients,
is of concern and generally thought to be caused by iron deficiency. Although
iron deficiency in this population may be frequent given pouch hypoacidity,
defunctionalized small bowel, and red meat intolerance, it may not account for
all anemias seen. First, there is increasing evidence that obesity creates a
state of chronic inflammation. Both iron deficiency anemia and anemia of
chronic inflammation present with low serum iron levels. Most studies
reporting anemia after bariatric surgery lack serum ferritin determinations so
that the relative contribution of inflammation to anemia cannot be assessed.
Second, a significant number of anemias after bariatric surgery remain
unexplained and may be attributable to less frequently seen micronutrient
deficiencies such as copper, fatsoluble vitamins A and E, or an imbalance in
zinc intake. Third, although deficiencies of folate and vitamin B<SUB>12</SUB>
are infrequent, study observation periods may be too short to detect anemia
attributable to vitamin B<SUB>12</SUB> deficiency because vitamin
B<SUB>12</SUB> storage depletion takes many years. This review is intended to
increase awareness of the mechanisms of anemia above and beyond iron
deficiency in the bariatric patient and provide healthcare providers with
tools for a more thoughtful approach to anemia in this patient population.</p>
]]></description>
<dc:creator><![CDATA[von Drygalski, A., Andris, D. A.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332174</dc:identifier>
<dc:title><![CDATA[Anemia After Bariatric Surgery: More Than Just Iron Deficiency]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>226</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>217</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/227?rss=1">
<title><![CDATA[Probiotics for Preventive Health]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/227?rss=1</link>
<description><![CDATA[
<p>Gut flora and probiotics have potential to affect health and disease far
beyond the gut. There is increasing evidence that probiotics have beneficial
effects in preventing a wide range of conditions and improving health.
Randomized, double-blind studies have provided evidence of the effectiveness
of probiotics for preventing various diarrheal illnesses as well as allergic
disorders. Evidence for their efficacy for use in the prevention and treatment
of bacterial vaginosis and urinary tract infections is also mounting. In
addition, probiotics may be useful for preventing respiratory infections,
dental caries, necrotizing enterocolitis, and certain aspects of inflammatory
bowel disease. Data also suggest that probiotics may promote good health in
day care and work settings, and may enhance growth in healthy as well as ill
and malnourished children. Results from meta-analyses and systematic reviews
that combine results of studies from different types of probiotics to examine
the effects in any disease state should be interpreted with caution. Specific
strains are effective in specific disease states. No 2 probiotics are exactly
alike; we should not expect reproducible results from studies that employ
different species or strains, variable formulations, and diverse dosing
schedules.</p>
]]></description>
<dc:creator><![CDATA[Minocha, A.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533608331177</dc:identifier>
<dc:title><![CDATA[Probiotics for Preventive Health]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>241</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>227</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/242?rss=1">
<title><![CDATA[Nutrition Support After Neonatal Cardiac Surgery]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/242?rss=1</link>
<description><![CDATA[
<p>Congenital heart disease is the most common birth defect in the United
States, with an estimated frequency of approximately 12&ndash;14 of 1000 live
births per year. Neonates with congenital heart disease often need palliative
or corrective surgery requiring cardiopulmonary bypass during the first weeks
of life. The neonate undergoing cardiopulmonary bypass surgery experiences a
more profound metabolic response to stress than that seen in older children
and adults undergoing surgery. However, compared with older children and
adults, the neonate has less metabolic reserves and is extremely vulnerable to
the negative metabolic impact induced by stress, which can lead to suboptimal
wound healing and growth failure. There are complications associated with the
metabolic derangements of neonatal surgery requiring cardiopulmonary bypass,
including but not limited to acute renal failure, chylothorax, and
neurological dysfunction. This article discusses the importance of nutrition
and metabolic support for the neonate undergoing cardiopulmonary bypass and
the immediate postoperative nutrition needs of such a patient. Also, this
article uses a case study to examine the feeding methodology used at one
particular institution after neonatal cardiac surgery. The purpose of the case
study is to provide an illustration of the many factors and obstacles that
clinicians often face in the provision and timing of nutrition support.</p>
]]></description>
<dc:creator><![CDATA[Owens, J. L., Musa, N.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332086</dc:identifier>
<dc:title><![CDATA[Nutrition Support After Neonatal Cardiac Surgery]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>249</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>242</prism:startingPage>
<prism:section>Invited Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/250?rss=1">
<title><![CDATA[Chemopreventive Role of Fruits and Vegetables in Oropharyngeal Cancer]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/250?rss=1</link>
<description><![CDATA[
<p>Oropharyngeal cancer is associated with lifestyle factors, including
tobacco use, dietary habits, and alcohol consumption. Oropharyngeal cancers
are one of the 10 most common types of cancers worldwide, and it is estimated
that oropharyngeal cancers will have affected 30,990 men and women in the
United States with a total of 7430 deaths in 2008. The National Cancer
Institute defines chemoprevention as "the use of drugs, vitamins, or
other agents to try to reduce the risk of, or delay the development or
reccurrence of, cancer." Chemopreventive agents such as antioxidants are
derived from dietary sources, including fruits and vegetables. This review
addresses the chemopreventive role of dietary intake of fruits and vegetables
in the development of oropharyngeal cancers. It focuses on the variability of
the incidence of oropharyngeal cancers and possible reasons behind this
phenomenon as it relates to dietary factors, specifically fruits and
vegetables.</p>
]]></description>
<dc:creator><![CDATA[Davidson, P. G., Touger-Decker, R.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332088</dc:identifier>
<dc:title><![CDATA[Chemopreventive Role of Fruits and Vegetables in Oropharyngeal Cancer]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>260</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>250</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/261?rss=1">
<title><![CDATA[Methods for the Assessment of Gastric Emptying in Critically Ill, Enterally Fed Adults]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/261?rss=1</link>
<description><![CDATA[
<p>Critically ill patients may experience delayed gastric emptying. Patients
receiving enteral feeding are monitored closely to detect a delay of gastric
emptying, assess feeding tolerance, and prevent aspiration pneumonia. The most
common practice for assessing gastric emptying is to measure the aspirated
gastric residual volume; however, this is an unreliable method that lacks
standardization, fails to differentiate normal digestive secretions from
enteral formula, and results in unnecessary interruptions of enteral
nutrition. The aim of this review is to identify an alternative method to
assess gastric emptying, which should be reliable, sensitive, harmless,
feasible, and inexpensive. Several techniques are discussed: scintigraphy,
paracetamol absorption test, breath tests, refractometry, ultrasound, and
gastric impedance monitoring. Refractometry seems to be the most appropriate
tool for the regular assessment of enteral nutrition; however, standardization
and validation of this method are needed before it can be routinely used to
monitor critically ill patients receiving enteral nutrition.</p>
]]></description>
<dc:creator><![CDATA[Moreira, T. V., McQuiggan, M.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332176</dc:identifier>
<dc:title><![CDATA[Methods for the Assessment of Gastric Emptying in Critically Ill, Enterally Fed Adults]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>273</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>261</prism:startingPage>
<prism:section>Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/274?rss=1">
<title><![CDATA[Comparison of Tools for Nutrition Assessment and Screening for Predicting the Development of Complications in Orthopedic Surgery]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/274?rss=1</link>
<description><![CDATA[
<p><I>Background:</I> Malnutrition in hospitalized patients is a significant
problem. The purpose of this study was to compare 2 assessment tools&mdash;the
Nutritional Risk Screening 2002 (NRS 2002) and subjective global assessment
(SGA)&mdash;in predicting development of complications in patients undergoing
orthopedic surgery. <I>Methods:</I> Nutrition status was assessed by the
SGA, and nutrition screening was performed using the NRS 2002 in 256
consecutively admitted patients scheduled for orthopedic surgery. Additional
information recorded for all patients included age, gender, body mass index,
and American Society of Anesthesiologists (ASA) physical status. Patient
outcomes (postoperative complications), mortality rate, and length of hospital
stay (LOS) were investigated. <I>Results:</I> Malnourished or nutritionally
at-risk patients were significantly older than nonmalnourished or not at-risk
patients according to the SGA and NRS 2002. Also, ASA physical status was
correlated with malnutrition or malnutrition risk. Malnourished and at-risk
patients in both the SGA and NRS 2002 groups showed longer LOS and higher
morbidity and mortality rates. Sensitivity was 50% with the SGA and 69% with
the NRS 2002; specificity was 77% with the SGA and 80% with the NRS 2002.
Agreement between 2 methods was 0.672. The odds ratio for the association
between malnutrition or risk of malnutrition and the occurrence of
complications was 3.5 (1.7-7.1) for the SGA and 4.1 (2.0-8.5) for NRS 2002.
<I>Conclusions:</I> Age and ASA physical status are risk factors for
malnutrition. In patients undergoing orthopedic surgery, NRS 2002 predicted
development of complications better than the SGA. Malnutrition also increased
length of hospital stay.</p>
]]></description>
<dc:creator><![CDATA[Ozkalkanli, M. Y., Ozkalkanli, D. T., Katircioglu, K., Savaci, S.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332087</dc:identifier>
<dc:title><![CDATA[Comparison of Tools for Nutrition Assessment and Screening for Predicting the Development of Complications in Orthopedic Surgery]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>280</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>274</prism:startingPage>
<prism:section>Clinical Research</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/content/abstract/24/2/281?rss=1">
<title><![CDATA[The "Cut and Push" Method of Percutaneous Endoscopic Gastrostomy Tube Removal in Adult Patients: The Ipswich Experience]]></title>
<link>http://ncp.sagepub.com/cgi/content/abstract/24/2/281?rss=1</link>
<description><![CDATA[
<p><I>Background:</I> The standard method of removing percutaneous
endoscopic gastrostomy (PEG) tubes in the United Kingdom is by repeat
gastroscopy and retrieval of the internal PEG bumper by the oral route.
However, the endoscopic removal method may not always be necessary by use of
the "cut and push" method. This involves cutting the tube at skin
level and allowing the internal bumper to pass naturally. <I>Methods</I>: A
local database of all patients undergoing a PEG insertion was created in
February 2002. All PEG tube removals by the "cut and push" method
over a 5-year period at Ipswich Hospital were reviewed. <I>Results</I>:
Between February 2002 and December 2007, 89 Fresenius Freka 15 Fr tubes were
removed by the "cut and push" method. The original indications for
the PEG tubes that were removed were head and neck malignancy (55),
cerebrovascular accident (24), and other miscellaneous causes (10). The mean
age of the patients was 62.7 years (range 19-98 years). The average duration
of the tube in-situ before removal was 6.7 months (range 1-28). No
complications were recorded during the mean follow-up period of 26.8 months
(range 1-66 months). <I>Conclusion</I>: Follow-up data provide further
evidence that the "cut and push" method is a safe and
cost-effective method for removing 15 Fr PEG tubes in adult patients and that
an abdominal radiograph is not routinely required.</p>
]]></description>
<dc:creator><![CDATA[Kejariwal, D., Bromley, D., Miao, Y.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533608323420</dc:identifier>
<dc:title><![CDATA[The "Cut and Push" Method of Percutaneous Endoscopic Gastrostomy Tube Removal in Adult Patients: The Ipswich Experience]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>283</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>281</prism:startingPage>
<prism:section>Clinical Observations</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/2/284?rss=1">
<title><![CDATA[]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/2/284?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Fink, K.]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609332085</dc:identifier>
<dc:title><![CDATA[]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>284</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>284</prism:startingPage>
<prism:section>Book Reviews</prism:section>
</item>

<item rdf:about="http://ncp.sagepub.com/cgi/reprint/24/2/285?rss=1">
<title><![CDATA[]]></title>
<link>http://ncp.sagepub.com/cgi/reprint/24/2/285?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Wed, 25 Mar 2009 16:12:03 PDT</dc:date>
<dc:identifier>info:doi/10.1177/0884533609334533</dc:identifier>
<dc:title><![CDATA[]]></dc:title>
<dc:publisher>The American Society for Parenteral &amp; Enteral Nutrition</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>24</prism:volume>
<prism:endingPage>286</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>285</prism:startingPage>
<prism:section>Meetings &amp; Conferences</prism:section>
</item>

</rdf:RDF>